Al Hussein Hassan S, Guerra Lauren M, Raza Syed Ali, Javalkar Vijaykumar, Raza Madiha
Department of Neurology (Medicine), Hamad General Hospital, Doha, QAT.
Neuroscience, Northwestern University, Evanston, USA.
Cureus. 2024 Jul 7;16(7):e64023. doi: 10.7759/cureus.64023. eCollection 2024 Jul.
This case presents a somewhat unique and different phenotype of hereditary spastic paraplegia from previously reported kinase D-interacting substrate of 220 kDa () gene mutation-related disease. We report a unique putative causative heterozygous mutation in in a pure hereditary spastic paraplegia (HSP) patient expanding the HSP group further. We also deliberate on how our case was different from prior -related pathologies including spastic paraplegia, intellectual disability, nystagmus, and obesity (SINO) syndrome, and the observation of and aquaporin-4 () downregulation in the ventricular ependymal lining of idiopathic normal pressure hydrocephalus (iNPH) patients. These findings warrant further investigations of the biology of . With the advent of new gene editing technologies like Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), variants such as ours provide an opportunity for targeted precision medicine.
该病例呈现出一种与先前报道的220 kDa激酶D相互作用底物()基因突变相关疾病有所不同的遗传性痉挛性截瘫独特表型。我们报告了一名单纯遗传性痉挛性截瘫(HSP)患者中一个独特的、可能致病的杂合突变,这进一步扩充了HSP群体。我们还探讨了我们的病例与先前包括痉挛性截瘫、智力残疾、眼球震颤和肥胖(SINO)综合征等相关病症的差异,以及在特发性正常压力脑积水(iNPH)患者脑室室管膜衬里中观察到的和水通道蛋白4()下调情况。这些发现值得对的生物学特性进行进一步研究。随着成簇规律间隔短回文重复序列(CRISPR)/CRISPR相关蛋白9(Cas9)等新基因编辑技术的出现,像我们发现的这种变异为靶向精准医学提供了机会。